Analysis of prognostic factors in acute lymphoblastic leukemia

Denman Hammond, Harland Sather, Mark Nesbit, Dennis Miller, Peter Coccia, Archie Bleyer, John Lukens, Stuart Siegel

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Children with ALL who have a high probability of excellent response, long‐term survival, and cure when treated with widely available standard therapy can be identified at the time of diagnosis. Others can be identified who are at high risk of failure to respond, early relapse, and death. The importance of such prognostic characteristics is so great that they should be considered in the selection of appropriate treatment for each patient. Prognostic factors also must be considered in the design and analysis of clinical trials. All prognostic factors are not equally significant and many of them are closely associated. It is possible to rank them in importance and usefulness by appropriate statistical methods. As additional prognostic factors are identified, and as more effective and more specific therapies are developed, the relative importance of prognostic factors will change.

Original languageEnglish (US)
Pages (from-to)124-134
Number of pages11
JournalMedical and Pediatric Oncology
Volume14
Issue number3
DOIs
StatePublished - 1986

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Therapeutics
Clinical Trials
Recurrence
Survival

Keywords

  • acute lymphoblastic leukemia
  • prognostic factors
  • relative importance

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Hammond, D., Sather, H., Nesbit, M., Miller, D., Coccia, P., Bleyer, A., ... Siegel, S. (1986). Analysis of prognostic factors in acute lymphoblastic leukemia. Medical and Pediatric Oncology, 14(3), 124-134. https://doi.org/10.1002/mpo.2950140305

Analysis of prognostic factors in acute lymphoblastic leukemia. / Hammond, Denman; Sather, Harland; Nesbit, Mark; Miller, Dennis; Coccia, Peter; Bleyer, Archie; Lukens, John; Siegel, Stuart.

In: Medical and Pediatric Oncology, Vol. 14, No. 3, 1986, p. 124-134.

Research output: Contribution to journalArticle

Hammond, D, Sather, H, Nesbit, M, Miller, D, Coccia, P, Bleyer, A, Lukens, J & Siegel, S 1986, 'Analysis of prognostic factors in acute lymphoblastic leukemia', Medical and Pediatric Oncology, vol. 14, no. 3, pp. 124-134. https://doi.org/10.1002/mpo.2950140305
Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Medical and Pediatric Oncology. 1986;14(3):124-134. https://doi.org/10.1002/mpo.2950140305
Hammond, Denman ; Sather, Harland ; Nesbit, Mark ; Miller, Dennis ; Coccia, Peter ; Bleyer, Archie ; Lukens, John ; Siegel, Stuart. / Analysis of prognostic factors in acute lymphoblastic leukemia. In: Medical and Pediatric Oncology. 1986 ; Vol. 14, No. 3. pp. 124-134.
@article{5cfb5a8584b346e6903d70780ef8bfb3,
title = "Analysis of prognostic factors in acute lymphoblastic leukemia",
abstract = "Children with ALL who have a high probability of excellent response, long‐term survival, and cure when treated with widely available standard therapy can be identified at the time of diagnosis. Others can be identified who are at high risk of failure to respond, early relapse, and death. The importance of such prognostic characteristics is so great that they should be considered in the selection of appropriate treatment for each patient. Prognostic factors also must be considered in the design and analysis of clinical trials. All prognostic factors are not equally significant and many of them are closely associated. It is possible to rank them in importance and usefulness by appropriate statistical methods. As additional prognostic factors are identified, and as more effective and more specific therapies are developed, the relative importance of prognostic factors will change.",
keywords = "acute lymphoblastic leukemia, prognostic factors, relative importance",
author = "Denman Hammond and Harland Sather and Mark Nesbit and Dennis Miller and Peter Coccia and Archie Bleyer and John Lukens and Stuart Siegel",
year = "1986",
doi = "10.1002/mpo.2950140305",
language = "English (US)",
volume = "14",
pages = "124--134",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Analysis of prognostic factors in acute lymphoblastic leukemia

AU - Hammond, Denman

AU - Sather, Harland

AU - Nesbit, Mark

AU - Miller, Dennis

AU - Coccia, Peter

AU - Bleyer, Archie

AU - Lukens, John

AU - Siegel, Stuart

PY - 1986

Y1 - 1986

N2 - Children with ALL who have a high probability of excellent response, long‐term survival, and cure when treated with widely available standard therapy can be identified at the time of diagnosis. Others can be identified who are at high risk of failure to respond, early relapse, and death. The importance of such prognostic characteristics is so great that they should be considered in the selection of appropriate treatment for each patient. Prognostic factors also must be considered in the design and analysis of clinical trials. All prognostic factors are not equally significant and many of them are closely associated. It is possible to rank them in importance and usefulness by appropriate statistical methods. As additional prognostic factors are identified, and as more effective and more specific therapies are developed, the relative importance of prognostic factors will change.

AB - Children with ALL who have a high probability of excellent response, long‐term survival, and cure when treated with widely available standard therapy can be identified at the time of diagnosis. Others can be identified who are at high risk of failure to respond, early relapse, and death. The importance of such prognostic characteristics is so great that they should be considered in the selection of appropriate treatment for each patient. Prognostic factors also must be considered in the design and analysis of clinical trials. All prognostic factors are not equally significant and many of them are closely associated. It is possible to rank them in importance and usefulness by appropriate statistical methods. As additional prognostic factors are identified, and as more effective and more specific therapies are developed, the relative importance of prognostic factors will change.

KW - acute lymphoblastic leukemia

KW - prognostic factors

KW - relative importance

UR - http://www.scopus.com/inward/record.url?scp=0022915421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022915421&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950140305

DO - 10.1002/mpo.2950140305

M3 - Article

C2 - 3462458

AN - SCOPUS:0022915421

VL - 14

SP - 124

EP - 134

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -